Llwytho...
Effect of sphingosine kinase modulators on interleukin‐1β release, sphingosine 1‐phosphate receptor 1 expression and experimental autoimmune encephalomyelitis
BACKGROUND AND PURPOSE: The sphingosine analogue, FTY720 (Gilenya(R)), alleviates clinical disease progression in multiple sclerosis. Here, we variously assessed the effects of an azide analogue of (S)‐FTY720 vinylphosphonate (compound 5; a sphingosine kinase 1 activator), (R)‐FTY720 methyl ether (R...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Br J Pharmacol |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5192795/ https://ncbi.nlm.nih.gov/pubmed/27864936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13670 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|